SCHEMBL9899175

SCHEMBL9899175

COc1ccc2c(O)cc(C(=O)O)c(-c3ccc(-c4ccccc4)cc3)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.47
FABP3 P05413 1/20 0.46
FABP4 P15090 1/20 0.46
LMNA P02545 4/20 0.45
HPGD P15428 4/20 0.45
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 3/20 0.45
NPC1 O15118 1/20 0.45
MAPT P10636 1/20 0.45
NFKB1 P19838 1/20 0.45
RAB9A P51151 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
ATM Q13315 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MAPK8 P45983 1/20 0.45
CYP1A2 P05177 2/20 0.45
PGR P06401 2/20 0.45
SLC6A2 P23975 2/20 0.45
CYP2C19 P33261 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17733182 0.92 FABP3 (0.47) SMN1; SMN2FABP3FABP4LMNAHPGD
SCHEMBL9896760 0.90 PLA2G2A (0.53) SMN1; SMN2LMNAHPGDALDH1A1KDM4E
SCHEMBL1514525 0.90 GPR35 (0.50) SMN1; SMN2FABP3FABP4LMNAHPGD
SCHEMBL6383991 0.88 SMN1; SMN2 (0.54) SMN1; SMN2LMNAHPGDALDH1A1KDM4E
SCHEMBL1010666 0.84 ACMSD (0.46) FABP3FABP4LMNAHPGDALDH1A1
SCHEMBL25876675 0.83 AKR1C3 (0.48) SMN1; SMN2LMNAHPGDALDH1A1KDM4E
SCHEMBL15765703 0.82 SMN1; SMN2 (0.48) SMN1; SMN2LMNAHPGDALDH1A1KDM4E
SCHEMBL9900350 0.81 THRB (0.61) HPGDKDM4EMAPTATMHNF4A
SCHEMBL2018471 0.81 FABP3 (0.47) FABP3FABP4LMNAHPGDALDH1A1
SCHEMBL9898544 0.79 KCNA5 (0.41) SMN1; SMN2HPGDALDH1A1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9028728-B2 Photochromic materials that include indeno-fused naphthopyrans TRANSITIONS OPTICAL, INC. (US) 2015-05-12 US disclosed
WO-2013086248-A1 PHOTOCHROMIC MATERIALS THAT INCLUDE INDENO-FUSED NAPHTHOPYRANS PPG INDUSTRIES, INC. (US) 2013-06-13 WO disclosed
US-20120145973-A1 Photochromic Materials That Include Indeno-Fused Naphthopyrans TRANSITIONS OPTICAL INC. (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120145973-A1 Photochromic Materials That Include Indeno-Fused Naphthopyrans NQO1, INTS6, IPO4 SMN1; SMN2 4652/4885FABP3 3278/4885FABP4 2518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.